language_icon
EN
HI

Aster DM Healthcare Share price

ASTERDM

753.65

7.05 (0.94%)
NSE
BSE
Last updated on 15 May, 2026 | 15:46 IST
Today's High

766.95

Today's Low

740.20

52 Week Low

519.10

52 Week High

770.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aster DM Healthcare Chart

Aster DM Healthcare Share Key Metrics

Volume
7.65 L
Market Cap
39048.19 CR
LTQ@LTP
50@753.65
ATP
755.39
Var Margin
16.32 %
Circuit Range
597.3-895.9
Delivery %
51.25 %
Value
57.77 CR
ASM/GSM
No
Market Lot
1

Summary

Aster DM Healthcare share price is ₹753.65 as of 16 May, 2026. The stock Aster DM Healthcare intraday movement has stayed between ₹740.20 and ₹766.95, while on a 52-week basis,Aster DM Healthcare price 52 week high is ₹770.00 & its 52 week low is ₹519.10.
In terms of trading activity, Aster DM Healthcare has recorded a volume of 764794 shares, The Aster DM Healthcare has a market cap of ₹518121029 CR. The stock’s Average Traded Price (ATP) stands at ₹755.39, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 50 @ ₹753.65.
Aster DM Healthcare operates within a circuit range of ₹597.30 – ₹895.90, with a Value of ₹57.77 CR. The Delivery Percentage for the day is 51.25%. Additionally, Aster DM Healthcare currently falls under the No framework, and trades with a market lot size of 1.

Aster DM Healthcare Fundamentals

View More
P/E Ratio

99.46

P/B Ratio

8.44

Div. Yield

0

Sector P/E

55.89

Sector P/B

-15.72

Sec. Div. Yield

2.01

Aster DM Healthcare Resistance and Support

Pivot 742.73

Resistance

First Resistance

754.36

Second Resistance

762.13

Third Resistance

773.76

Support

First Support

734.96

Second Support

723.33

Third Support

715.56

Aster DM Healthcare Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

40.39%

Mutual Fund

26.45%

Insurance

0.67%

Foreign Institutional Investors

17.18%

Domestic Institutional Investors

0.45%

Retail

14.85%

Others

0.01%

Total Promoters
MAR '26
40.39%

Aster DM Healthcare Corporate Actions

DateAgenda
2026-04-30Audited Results
2026-03-26Interim Dividend
2026-01-30Quarterly Results & ESOP
2025-11-06Quarterly Results & ESOP
2025-07-30Quarterly Results
2025-05-20Audited Results & Final Dividend
2025-01-31Quarterly Results & Interim Dividend

Aster DM Healthcare News

Here's why these two healthcare stocks are surging up to 18% on Monday

Aster DM Healthcare has completed the separation of its GCC business, transitioning into an India-focused healthcare company and receiving $903 million (₹7,500 crore) in cash consideration. Following this, the company declared a special dividend of ₹118 per share, with the record date fixed as April 23, 2024. Additionally, the company announced plans for significant expansion in India, aiming to add 1,500 beds by 2029, and appointed Alisha Moopen as Managing Director and Azad Moopen as Founder & Chairman.
May 04 2026 13:05:00

Here's why these two healthcare stocks are surging up to 10% on Monday

Shares of Aster DM Healthcare rallied up to 10% on Monday, driven by strong buying interest from analysts and investors. This surge is primarily attributed to the company's recent divestment of its Gulf business to Alpha GCC Holdings for a cash consideration of $1.01 billion (₹8,000 crore).
May 04 2026 11:05:00

Aster DM Healthcare profit jumps 77% on strong patient growth and lab performance

Aster DM Healthcare reported a 77% year-on-year jump in profit for the fourth quarter of fiscal year 2026. The substantial increase was attributed to robust performance driven by strong patient growth and improved lab services.
Apr 30 2026 16:04:00

Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Aster DM Healthcare announced robust Q4 FY26 financial results, with revenue growing 18% YoY to Rs.1,182 cr. Normalized net profit saw a significant 45% YoY increase to Rs.153 cr, driven by strong operating EBITDA growth.
Apr 30 2026 16:04:00

Aster DM Healthcare Ltd - 540975 - Board Meeting Outcome for Outcome Of The Board Meeting Held On April 30, 2026

Aster DM Healthcare's board approved its Q4 and full FY26 cons. audited financial results. For Q4 FY26, cons. revenue was ₹1,182.38 cr and profit ₹153.58 cr. For the full FY26, cons. revenue reached ₹4,643.22 cr and profit ₹427.10 cr. Deloitte Haskins & Sells issued an unmodified audit opinion.
Apr 30 2026 15:04:00

Aster DM Healthcare Limited

Aster DM Healthcare board is scheduled to meet on April 30, 2026, to consider and approve its audited standalone and consolidated financial results for the year ended March 31, 2026.
Apr 25 2026 14:04:00

Aster DM Healthcare Limited

Aster DM Healthcare's Board will convene on April 30, 2026, to approve its audited standalone and consolidated financial results for the quarter and fiscal year ended March 31, 2026. This key meeting will finalize the company's annual performance figures.
Apr 25 2026 14:04:00

Aster DM Healthcare Limited

Aster DM Healthcare completed the acquisition of a 26% stake in Oyster Green Hybrid Two Private Limited for a revised consideration of ₹5.80 crores. This acquisition involves a captive solar power plant project in Kerala for electricity requirements.
Apr 23 2026 16:04:00

Aster DM Healthcare Limited

Aster DM Healthcare disclosed its Q4 FY26 shareholding pattern. The promoter and promoter group hold 40.39% of the shares, with 40.66% of their holding encumbered by pledge. Public shareholders account for 59.38% of the company.
Apr 21 2026 17:04:00
Read More

About Aster DM Healthcare

NSE : 1508  
BSE : 540975  
ISIN : INE914M01019  

The Company was incorporated as DM Healthcare Private Limited on January 18 2008 at Kochi Ernakulam Kerala India as a private limited company under the Companies Act 1956. The name of the Company was changed to Aster DM Healthcare Private Limited and a fresh certificate of incorporation consequent upon change of name was issued on November 29 2013. The name of the Company was changed from DM Healthcare Private Limited to Aster DM Healthcare Private Limited to align theselves with the brand name ‘Aster’ and leverage the value of the brand.Major events and milestones of the Company1987- The Promoter Dr. Azad Moopen started a clinic in Dubai1995- The first specialty medical centre was launched in Dubai2001- MIMS Kozhikode Hospital commenced operations2005- Al Rafa Hospital for Maternity and Surgery (now called Aster Day Surgery Centre LLC) commenced operations2006- Medcare Hospital commenced operations2008- India Value Fund III A acquired 28.20% of the paid up Equity Share capital the Company calculated at the time ofinvestment- The Company acquired majority stake in PHL Kolhapur2009- Al Raffah Hospital the first hospital in Oman commenced operations in Muscat2010- The Company acquired 100% of the paid up equity share capital of Affinity Mauritius- Al Raffah Hospital the second hospital in Oman commenced operations in Sohar2011- Second Medcare Hospital namely Medcare Orthopedics and Spine Hospital (Dubai) commenced operations2012- Olympus acquired 25.47 % of the paid up equity share capital of the Company- 40.80% of the paid up equity share capital of Sanad Al Rahma for Medical Care LLC was conditionally acquired2013- The Company acquired 60.35% of the paid up equity share capital of IHPL and consequently MIMS became the Subsidiary.2014- The Company acquired hospital operational and management rights in Aster CMC Bangalore pursuant to the hospital operation and management agreement dated May 12 2014- Aster Medcity was inaugurated in Kochi Kerala- The Company acquired 51% voting rights in Sainatha Hospitals Andhra Pradesh- We acquired 54% stake in Aster Kuwait- We acquired 51% stake in Orange Pharmacies LLC Jordan2015- First clinic in the Kingdom of Bahrain commenced operations- First clinic in the Philippines commenced operations2016- The Company divested its stake in Medipoint Hospitals Private Limited Pune- The Company acquired hospital operational and management rights in DM Wayanad Institute of Medical Sciences Wayanad pursuant to a medical services agreement and an operation and management agreement both dated March 4 2016- The Company increased stake up to 70.68% in the paid up equity share capital of MIMS- We increased stake up to 97% stake in Sanad Medical Care- Acquisition of 51% stake in Dr Ramesh Hospital- The second clinic in Bahrain commences operations- Medcare Women and Child Hospital in Dubai was launched- Launch of the first multi-specialty hospital in Sharjah2017- Entered into an operation and management agreement with the Rashtreeya Sikshana Samithi Trust to operate and manage a hospital in Bengaluru- Medare Hospital Sharjah commenced operations- Aster Hospital Doha commenced operations Awards and Accreditations 2001- MIMS Hospital Kozhikode India received the first place (certificate of merit) from the Kerala State Pollution Control Board for making a substantial and sustained effort in pollution control. MIMS subsequently received this certificate of merit in 2007 2008 2009 2010 2011 2012 and 2013 for various hospitals2006- MIMS Hospital Kozhikode India received NABH accreditation valid upto October 29 2009 which was subsequently renewed up to October 29 20182012- MIMS Laboratory Services MIMS received ISO 15189:2007 certification in the field of Medical Testing valid up to October 8 2016 which was subsequently renewed as ISO 15189:2012 up to October 8 20182013- Medcare Hospital LLC Dubai UAE received JCI accreditation valid up to December 21 2016 which was subsequently renewed up to November 10 2019- Medcare Orthopaedics and Spine Hospital Dubai UAE received JCI accreditation valid up to December 19 2016 which was subsequently renewed up to November 16 20192014- Aster Pharmacy Group received the Best Service Performance Brand Award by Dubai Service Excellence Scheme2015- Aster Medcity Kochi India received NABH accreditation for compliance with the Certification Standards for Nursing Excellence valid up to March 30 2017 which was subsequently renewed up to March 30 2019- Aster Medcity Kochi India received NABH accreditation valid up to March 30 2018- Aster Medcity Kochi India received the ISO 22000:2005 certification for production and service of food for patients staff and patients’ relatives within the hospital from Bureau Veritas Certification Holding SAS – UK Branch valid up to July 16 2018- Aster Pharmacies Group LLC has been awarded ‘Superbrand’ status by the UAE Superbrands Council- Aster Medcity Kochi India received JCI accreditation valid up to June 19 2018- The Company received the ‘National Awards for Excellence in Healthcare Award for Best Dialysis Service Provider’ by CMO Asia- The Company received the ‘National Awards for Excellence in Healthcare Award for Best Marketing Campaign – Healthcare Industry’ by CMO Asia- The Company received the ‘National Awards for Excellence in Healthcare Award for Best Healthcare Entreprenuer’ by CMO Asia- Dr. Ramesh Hospital (Labbipet branch) received NABH – entry level accreditation which is valid up to September 25 2019- Aster Aadhar Hospital Pune Maharashtra received NABH accreditation which is valid up to June 3 2018- Aster Jubilee Medical Complex Dubai received JCI accreditation which is valid up to September 3 2018- Al Raffah Hospital Sohar received JCI accreditation which is valid up to August 26 20182016- The Company received the ‘Institutional Bravery Award’ for Distinguished Service in Flood Relief in Chennai and Cuddalore 2015 by the Society for Emergency Medicine India- Aster Hospital Mankhool Dubai received JCI accreditation which is valid up to June 2 2019- Aster Medcity Kochi India received the ‘Quality Beyond Accreditation Award’ by the Association of Healthcare Providers (India)- The Company received the ‘National Awards for Excellence in Healthcare Award for Best Healthcare Entreprenuer’ by CMO Asia- Aster Medcity Kochi India received the ‘Dhanam Award 2016 - NRK Brand of the Year’ award- Aster Medcity Kochi India received the ‘Distinction in Quality of Service Delivery Award’ by Asia Healthcare- Aster Medcity Kochi India received the ‘Nursing Excellence Award’ by the Association of Healthcare Providers (India)- Aster Medcity Kochi India received the ‘Award for Best Quality Initiative in Healthcare’ by Asia Healthcare- The Company received the ‘Award for the Best Marketing Campaign’ by Asia Healthcare- The Company received the ‘National Awards for Excellence in Healthcare Award for Best Marketing Campaign’ by CMO Asia- Aster Medcity Kochi India received the Certificate of Honor from the NABH for being ‘One of the Best & Safest Hospitals in India’- Aster Medcity Kochi India received the first place (certificate of merit) from the Kerala State Pollution Control Board for making a substantial and sustained effort in pollution control- The Clinical Laboratory Services at Dr. Ramesh Hospital received NABL accreditation for medical testing in the disciplines of clinical biochemistry clinical pathology haematology and immunohaematology which is valid up to July 24 2018- The Clinical Laboratory Services at Dr. Ramesh Hospital received NABL accreditation in medical testing which is valid up to September 5 2018- Dr. Ramesh Hospital (Guntur branch) has received NABH accreditation which is valid up to September 26 2019- We received the “Qadat Al Tagheer Award 2016” for Excellence in Healthcare Sector- We received the Frost and Sullivan ME growth award for Health Awareness Campaign of the Year UAE (2016)- Aster Pharmacies Group received the Dubai Quality Appreciation Award for 2016 from the Government of Dubai- Aster Pharmacy received the Best Service Performance Brand Award by Dubai Service Excellence Scheme2017- Aster CMI hospital received the ‘Best Hospitality in Healthcare’ award from the Times Network- Aster CMI hospital has been ranked as the 23rd best multi specialty hospital (national rankings) 7th best multi specialty hospital (South India) and 2nd best multi specialty hospital in Bangalore in the All India Multispecialty Hospital Ranking Survey 2017 by the Times Group- Aster CMI hospital has been ranked 12th in cardiac sciences (national rankings) 3rd in cardiac sciences (South India) and 2nd in cardiac sciences in Bangalore in the All India Critical Care Hospital Ranking Survey 2017 by the Times Group- Aster CMI hospital has been ranked 6th in nephrology (South India) and 3rd in nephrology in Bangalore in the All India Critical Care Hospital Ranking Survey 2017 by the Times Group- Aster CMI hospital has been ranked 11th in gastroenterology and hepatology (South India) and 3rd in gastroenterology and hepatology in Bangalore in the All India Critical Care Hospital Ranking Survey 2017 by the Times Group- Aster CMI hospital has been ranked 4th in neuro sciences Bangalore and 4th in urology in Bangalore in the All India Critical Care Hospital Ranking Survey 2017 by the Times Group- Aster CMI hospital has received the ‘CMO Asia Presents Asia Healthcare Excellence Award’ in the ‘best hospitality in healthcare’ category- Dr. Ramesh Hospital has received the Healthcare Excellence Award 2017 for Patient Centricity from FICCI

Read More

Aster DM Healthcare Management

NamePosition
Azad MoopenChairman & Managing Director
Alisha MoopenDeputy Managing Director
View More

Aster DM Healthcare FAQs

The Buying Price of Aster DM Healthcare share is 753.65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Aster DM Healthcare stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aster DM Healthcare, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Aster DM Healthcare shares is 99.46. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Aster DM Healthcare shares is 8.44. Useful to assess the stock's value relative to its book value.

To assess Aster DM Healthcare’s valuation compare Sector P/E, P/B which are 55.89 & -15.72 with sector averages, along with growth rates and financial metrics.

The Market Cap of Aster DM Healthcare is 39048.19 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Aster DM Healthcare share price is 770.00 & 519.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Aster DM Healthcare belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost